DOI QR코드

DOI QR Code

Evaluation of the reduced scalp dose at Volumetric Modulated Arc Therapy(VMAT)

전뇌조사의 체적변조회전치료 시 두피선량 감소에 관한 평가

  • Kim, Jeong-Ho (Department of Radiation Oncology, Konyang University Hospital) ;
  • Bae, Seok-Hwan (Division of Radiology, Konyang University) ;
  • Kim, Ki-Jin (Department of Nuclear Medicine, Konyang University Hospital) ;
  • Yoo, Se-Jong (Department of Radiology, Konyang University Hospital)
  • 김정호 (건양대학교병원 방사선종양학과) ;
  • 배석환 (건양대학교 방사선학과) ;
  • 김기진 (건양대학교병원 핵의학과) ;
  • 유세종 (건양대학교병원 영상의학과)
  • Received : 2014.07.15
  • Accepted : 2014.10.10
  • Published : 2014.10.31

Abstract

The use of WBRT(whole brain radiation therapy) has increased due to the increase in the incidence of metastatic brain tumors. The development of radiation therapy techniques is expected to improve the quality of life. The VMAT (Volumetric Modulated Arc Therapy) is an excellent treatment technique that can distinguish the dose in each volume. Therefore, this study compared conventional WBRT and VMAT for hair loss according to the scalp dose using a head phantom. The CI (Conformity Index), HI (Homogeneity Index) and QOC (Quality of Coverage) were measured brain tissue. A 20 percent and 50 percent dose was measured at the scalp, eyeball, lens, and c-spine. Conventional WBRT is excellent at 10 percent of brain tissue. VMAT is far superior at 1000 percent at the other organs. VMAT at the prescribed dose can be used as radiation therapy of metastatic brain tumors with less hair loss.

전이성 뇌종양의 증가에 따라 전뇌 방사선치료가 증가하게 되었다. 그리고 치료기법의 발전은 삶의 질 향상의 중요성을 증가시키게 되었다. 체적변조회전 전뇌조사는 용적별 선량을 차등시킬 수 있는 우수한 치료기법이다. 이에 두피선량 증가에 따른 탈모에 대하여 기존 전뇌조사와 체적변조회전 전뇌조사를 비교하고자 하였다. 두정부 인체모형을 이용하여 치료계획을 비교하였다. 뇌 실질의 경우 정합지수, 동질성지수, 범위의 질지수를 적용하였으며, 두피, 안구, 수정체, 경추의 경우 20%선량의 용적, 50%선량의 용적을 적용하여 비교하였다. 비교결과 뇌 실질은 기존 전뇌조사가 10%정도 우수하였지만, 두피, 안구, 수정체, 경추의 경우는 체적변조회전 전뇌조사가 1000%정도 우수하였다. 향후 체적변조회전 전뇌조사의 처방선량을 조정한다면 탈모를 방지하는 전이성 뇌종양 방사선치료로 선정될 것이다.

Keywords

References

  1. J. H. Lee, K. Y. Choi, I. Y. Kim, et al., "Usefulness of 11C-methionine PET in the Diagnosis and Management of Tumor Seeding after Stereotactic Biopsy -Case Report-", Brain Tumor Research and Treatment, pp. 149-154, Jun, 2014.
  2. D. S. Sun, L. K. Hu, Y. Cai, et al., "A Systematic Review of Risk Factors for Brain Metastases and Value of Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer", Asian Pacific Journal of Cancer Prevention, pp. 1233-1239, Apr, 2014. DOI: http://dx.doi.org/10.7314/APJCP.2014.15.3.1233
  3. F. Andre, K. Slimane, T. Bachelot, et al., "Breast cancer with synchronous metastases: trends in survival during a 14-year period", J Clin Oncol, pp. 3302-3308, Feb, 2004. DOI: http://dx.doi.org/10.1200/JCO.2004.08.095
  4. A. Zabel, S. Milker-Zabel, C. Thilmann, et al., "Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors", Lung Cancer, pp. 87-94, Jul, 2002. DOI: http://dx.doi.org/10.1016/S0169-5002(02)00030-2
  5. J. S. Lee, "Cancer Facts & Figures 2014 in the Republic of Korea", Ministry of Health & Welfare Republic of Korea, pp. 1-138, Jul, 2014.
  6. K. W. Jung, Y. J. W, H. J. Kong, et al., "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011", Cancer Res Treat, pp. 109-123, Apr, 2014.
  7. W. S. Lee, Y. H. Kim, J. H. Han, et al., "Stereotactic Radiosurgery for Brain Metastases from Non-Small Cell Lung Cancer", Brain Tumor Research and Treatment, pp. 38-44. Feb, 2012.
  8. C. H. Lee, "The role of surgical resection in managements of brain metastasis : a 17-year longitudinal study", Seoul National University, pp. 1-32, Sep, 2012.
  9. E. J. Kim, "Study on antitumor effect of poly-gamma-glutamate in combination with cyclophosphamide", University of Science & Technology, pp. 1-54, Aug, 2013.
  10. M. K. Kang, "Comparison of the Dose of the Normal Tissues among Various Conventional Techniques for Whole Brain Radiotherapy", The Korean Society for Radiation Oncology, pp. 99-105, Apr, 2010. https://doi.org/10.3857/jkstro.2010.28.2.99
  11. D. W. Andrews, C. B. Scott, P. W. Sperduto, A. E. Flanders, L. E. Gaspar, M. C. Schell, et al., "Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial", The Lancet, pp. 1665, May, 2004. DOI: http://dx.doi.org/10.1016/S0140-6736(04)16250-8
  12. J. Y. Jang, S. Y. Park, J. S. Kim, et al., "Scalp Dose Evaluation According Radiation Therapy Technique of Whole Brain Radiation Therapy", Korea Society Radiotherapeutic Technology, pp. 103-108, Aug, 2011.
  13. M. H. Jang, "The Influence of Wearing Wigs on the Quality of Life the Female Cancer Patients Who Started Losing Hair", Kosin University, pp. 1-132, Feb, 2008.
  14. L. Feuvret, G. Noel, J. J. Mazeron, "Conformity index: A review", Int J Radiation Oncology Biol Phys, 64, pp. 333-342, 2006. DOI: http://dx.doi.org/10.1016/j.ijrobp.2005.09.028
  15. W. R. Lee, L. Daniel, RTOG 0415: A phase III randomized study of hypofractionated 3D-CRT/IMR versus conventionally fractionated 3D-CRT/IMRT in patients with favorable-risk prostate cancer, Radiation Therapy Oncology Group, Mahul, 2009.
  16. H. D. Kim, B. Y. Kim, S. J. Kim, et al. "Influence of Couch and Collimator on Dose Distribution of RapidArc Treatment Planning for Prostate Cancer in Radiation Therapy", Korean J Med Phys, pp. 99-105, Jun, 2012.
  17. H. J. Park, M. H. Kim, M. Chun, et al. "Effects of Arc Number or Rotation Range upon Dose Distribution at RapidArc Planning for Liver Cancer", Korean J Med Phys, pp. 165-173, Jun, 2012.
  18. Korean institute of radiological & medical sciences, Researh on the Medical Preparedness for Radiological Emergencies and the International Co-operation in the Region of the Far East Asia, Ministry of Science, ICT and Future Planning, Korea, 2002.